ArticleBone marrow transplantation2014

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: a pilot study.

L G Lum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.